Helping to Ensure the Success of a Phase III Vaccine Trial
The success of the trial required rapid training and onboarding of all trial sites to ensure their readiness to enroll patients during the rainy season. The Longboat platform, now part of Advarra, was used to provide training for every staff member at every trial site, inclusive of real-time training reports, helping to ensure all 20,000 patients enrolled were treated exactly according to protocol.
Download the case study to find out how a top-20 pharmaceutical company planned a large Phase III trial of a new vaccine for a mosquito-borne viral disease and achieved 97% training compliance.
Who Should Watch?
Certificate of Attendance
Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour